Stock listing

CADL Stock Price, News, Filings & Events — Candel Therapeutics, Inc.

Selected listing: CADL · BOATS · USD · US

This page tracks Candel Therapeutics, Inc.'s CADL:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CADL:BOATS. CADL:BOATS is the stock-level entry point for investors researching Candel Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Candel Therapeutics, Inc. (ticker: CADL) is a public company operating in the American market, with a market capitalization of approximately $700.5 million. The company focuses on developing innovative therapies for cancer treatment. Candel is committed to advancing its pipeline of therapeutics to improve patient outcomes.

CADL:BOATSUSDUSUpdated September 11, 2026
Candel Therapeutics, Inc. logo
Ticker
CADL:BOATS
Asset type
Stock
Market cap
$806.9M
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Candel Therapeutics, Inc. CADL:BOATS stock context

This page tracks Candel Therapeutics, Inc.'s CADL:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CADL:BOATS. CADL:BOATS is the stock-level entry point for investors researching Candel Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Candel Therapeutics, Inc. (ticker: CADL) is a public company operating in the American market, with a market capitalization of approximately $700.5 million. The company focuses on developing innovative therapies for cancer treatment. Candel is committed to advancing its pipeline of therapeutics to improve patient outcomes.

Latest news from Candel Therapeutics, Inc.

All Candel Therapeutics, Inc. news →

Research Candel Therapeutics, Inc.

Alternate listings